Human embryonic stem cell trials to begin
From: AFP
September 22, 2011 9:56PM

A US biotech company said today it will soon begin the first-ever European trials using human embryonic stem cells in an experimental treatment for people with a form of juvenile blindness.

The Massachusetts-based Advanced Cell Technology (ACT) said the trials will involve 12 patients with Stargardt's disease and will be based at Moorfields Eye Hospital in London, with more European sites planned for the future.

"This is the first time an embryonic stem cell trial has ever been approved anywhere else in the world," said Bob Lanza, chief scientific officer at ACT and a longtime researcher in human embryonic stem cells.

more...

http://www.theaustralian.com.au/news...-1226144017221